Sheena McCormack

Tracker trials (multiple letters)

D Dunn, Sheena McCormack, A Babiker, 2000 .

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

Sheena McCormack, Helen Rees, Heiner Grosskurth, 2010, The Lancet.

The averted infections ratio: a novel measure of effectiveness of experimental HIV pre-exposure prophylaxis agents.

Sheena McCormack, David V Glidden, S. McCormack, 2018, The lancet. HIV.

The potential for central monitoring techniques to replace on-site monitoring: findings from an international multi-centre clinical trial

Sheena McCormack, Nicola Joffe, S. McCormack, 2012, Clinical trials.

Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort.

Sheena McCormack, Graham Cooke, Placid Ugoagwu, 2013, World journal of gastroenterology.

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

Sheena McCormack, Anne M Johnson, Christine Bowman, 2016, The Lancet.